Get the latest news, insights, and market updates on BSX (Boston Scientific Corporation). Explore the news page 2 on MyTopStock.com for investor discussions, analysis, and real-time stock performance coverage.
Boston Scientific (BSX) Valuation After Mixed Q4 2025 Results And 2026 Growth Outlook
Boston Scientific (BSX) is in focus after reporting Q4 2025 and full year results that combined higher sales and earnings with mixed signals in key growth areas and guidance for 2026. See our latest analysis for Boston Scientific. The share price has retreated sharply in recent months, with a 30 day share price return of 20.28% and a 90 day return of 27.23%. However, the 3 year total shareholder return of 60.57% and 5 year total shareholder return of 96.50% remain well above these short term... Feb 14, 2026 - $BSX
Boston Scientific to participate in TD Cowen's 46th Annual Health Care Conference
Boston Scientific Corporation (NYSE: BSX) will participate in TD Cowen's 46th Annual Health Care Conference on Tuesday, March 3, 2026. Mike Mahoney, chairman and chief executive officer, and Kenneth Stein, M.D., senior vice president and global chief medical officer, will participate in a 30-minute question-and-answer session with the host analyst at approximately 9:10 a.m. ET. Feb 13, 2026 - $BSX
The Top 5 Analyst Questions From Boston Scientific’s Q4 Earnings Call
Boston Scientific’s fourth quarter results were met with a significant negative market reaction, despite meeting revenue expectations and delivering adjusted earnings above analyst consensus. Management pointed to broad-based growth, with electrophysiology (EP), WATCHMAN, interventional oncology, and neuromodulation cited as standouts. However, concerns emerged around sequential stagnation in U.S. EP sales and a modest miss in U.S. WATCHMAN, both key franchises for Boston Scientific’s ongoing mo Feb 11, 2026 - $BSX
4 takeaways from the 2026 AF Symposium
Johnson & Johnson, Boston Scientific and Abbott were among the companies showcasing new data on atrial fibrillation treatments, including pulsed field ablation catheters. Feb 10, 2026 - $BSX
Jim Cramer on Becton, Dickinson: “I Kind of Really Like the New Company”
Becton, Dickinson and Company (NYSE:BDX) is one of the stocks in focus on Jim Cramer’s game plan. Cramer showed bullish sentiment toward the company, as he said: Now, there’s been some incredible moves happening in the medical devices distribution space this quarter. The once unsinkable Boston Scientific got clobbered this week because the competition got […] Feb 10, 2026 - $BSX
Boston Scientific Board Change Puts Growth And Risk Oversight In Focus
Boston Scientific (NYSE: BSX) board member Yoshiaki Fujimori will not stand for re election at the upcoming annual meeting. Fujimori has served on the board for nearly a decade and currently chairs the Risk, Science and Technology Committee. His decision marks a change in board leadership and risk oversight at an important moment for the company. For investors watching Boston Scientific, this board shift comes after a challenging stretch for the share price. NYSE: BSX closed at $74.12, with... Feb 10, 2026 - $BSX
We use cookies and similar technologies to collect and process data such as browsing activity or unique identifiers.
Selecting "Allow All" to help us understand site usage and improve the platform.
Choosing "Essential Cookies Only" enables only the cookies necessary for core site functions, such as staying logged in.
For more information, please see our Privacy Policy.
Continue with Google
Continue with Facebook
Continue with Microsoft
Continue with Apple